Alkermes (NASDAQ: ALKS) reported Q1 EPS of $0.01, $0.07 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $246.2 million versus the consensus estimate of $228.23 million.

• Company Withdraws Previously Provided 2020 Financial Expectations Due to COVID-19 Uncertainties

For earnings history and earnings-related data on Alkermes (ALKS) click here.